Back
Open Access

Atherosclerosis regression and low LDL-C.

Session: PCSK9 inhibitors: the evidence-based story
Topic: Atherosclerosis
Speaker: Professor S. Nicholls (Melbourne, AU)
Sponsored by Amgen GmbH
Event: ESC Congress 2017

Congress Presentation

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)
51 presentations
4 followers

5 more presentations in this session

Introduction - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

Access
Video
Thumbnail

The LDL-C paradigm.

Speaker: Professor B. Ference (Cambridge, GB)

Access
Video
Thumbnail

Evidence for CV event reduction with lower LDL-C.

Speaker: Professor C. Packard (Glasgow, GB)

Access
Video
Thumbnail

Panel discussion - PCSK9 inhibitors: the evidence-based story.

Speaker: Professor K. Ray (London, GB)

Access
Video
Thumbnail

What questions remain unanswered?

Speaker: Professor K. Ray (London, GB)

Access
Video
Thumbnail

Access the full session

PCSK9 inhibitors: the evidence-based story

Speakers: Professor S. Nicholls, Professor K. Ray, Professor B. Ference, Professor C. Packard, Professor K. Ray...
Access
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb